Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | CVS | TMO |
|---|
| Close | 90.25 | 697.00 |
| Market Cap | $116B | $258B |
| 1M | +5.32% | +3.25% |
| P/E (TTM) | 23.8 | 36.4 |
| Forward P/E | 10.4 | 24.6 |
| P/E 5-Yr Percentile | 65 | 78 |
| P/S | 0.3 | 5.4 |
| P/B | 1.5 | 4.7 |
| Dividend Yield | 3.49% | 0.29% |
| Latest Quarter Revenue | $106B | $12.1B |
| Revenue YoY | +7.3% | +9.1% |
| Gross Margin | 44.5% | — |
| Latest Quarter EPS | 2.31 | 4.64 |
| Avg Post-Earnings Move | ±2.3% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.94% | 1.82% |
| 90-Day Net Insider Buying | — | −$40.3M |
CVS · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
